Adult-type Diffuse Gliomas

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-12-30
Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations [Phase 2]
Phase 2 trial of pemigatinib in previously treated glioblastoma and other primary CNS tumors with FGFR1-3 alterations was terminated; result…